This report should not be construed as providing investment advice. It is for educational purposes only.  Before making any investment decision, you should always do your own research or consult a investment professional. Estimates Estimates Estimates Power calculations see Aden
While I try to be accurate, I assume no responsibility for any figure in this spreadsheet. Q1 2025 <-Estimates
See my website on stocks or see my blog at the following sites.  https://spbrunner.com/stocks.html https://spbrunner.blogspot.com/ 3/31/25 <-Estimates
Well Health Technologies Corp TSX WELL OTCQX WHTCF https://well.company/ Fiscal Yr: Dec 31
Year 10/30/11 10/30/12 10/30/13 10/30/14 10/30/15 10/30/16 10/30/17 12/31/18 12/31/19 12/31/20 12/31/21 12/31/22 12/31/23 12/31/24 12/31/25 12/31/26 12/31/27 Description #Y Item Total G
Cost of Sales $7.4 $21.8 $29.0 $148.6 $265.8 $403.8 $556.7 $604.0 <-12 mths 8.50% 7398.32% <-Total Growth 6 Cost of Sales
Change 193.93% 33.01% 412.08% 78.86% 51.89% 37.86% 8.50% <-12 mths -77.55% -412.17% <-Median-> 5 Change
Ratio 0.70 0.67 0.58 0.49 0.47 0.52 0.61 0.61 <-12 mths 1.59% 0.58 <-Median-> 6 Ratio
General & Admin & Finance Chg $4.8 $12.0 $24.3 $111.5 $224.9 $284.4 $343.8 $362.1 <-12 mths 5.30% 7073.71% <-Total Growth 6 General & Admin
Change 150.05% 102.87% 358.63% 101.71% 26.46% 20.88% 5.30% <-12 mths -74.60% -618.50% <-Median-> 5 Change
Ratio 0.45 0.37 0.48 0.37 0.40 0.37 0.37 0.37 <-12 mths -1.40% 0.37 <-Median-> 6 Ratio
Total $12.2 $33.8 $53.3 $260.1 $490.8 $688.2 $900.5 $966.1 <-12 mths 7.28% 7270.97% <-Total Growth 6 Total
Change 176.71% 57.77% 387.72% 88.66% 40.23% 30.85% 7.28% <-12 mths -76.40% -472.89% <-Median-> 5 Change
Ratio 1.16 1.03 1.06 0.86 0.86 0.89 0.98 0.98 <-12 mths 0.45% 0.98 <-Median-> 6 Ratio
$982 <-12 mths 6.80% Estimates last 12 months from Qtr.
Revenue* $10.6 $32.8 $50.2 $302.3 $569.1 $776.1 $919.7 $1,413.0 $1,547.0 $1,689.0 8609.33% <-Total Growth 6 Revenue
Increase 0.00% 210.71% 53.12% 501.76% 88.25% 36.36% 18.51% 53.64% 9.48% 9.18% 110.54% <-IRR #YR-> 6 Revenue #DIV/0!
5 year Running Average $193.0 $346 $523.5 $796.0 $1,045.0 $1,268.9 94.77% <-IRR #YR-> 5 Revenue 2703.01%
Revenue per Share $0.13 $0.28 $0.31 $1.45 $2.46 $3.21 $3.69 $5.59 $6.12 $6.68 64.69% <-IRR #YR-> 2 5 yr Running Average #DIV/0!
Increase 121.92% 8.57% 368.98% 70.41% 30.49% 14.86% 51.32% 9.48% 9.18% 64.69% <-IRR #YR-> 2 5 yr Running Average #DIV/0!
5 year Running Average $0.93 $1.54 $2.22 $3.28 $4.21 $5.06 75.14% <-IRR #YR-> 6 Revenue per Share #DIV/0!
P/S (Price/Sales) Med 3.83 3.95 15.62 2.46 1.59 1.33 1.43 0.99 0.00 0.00 67.04% <-IRR #YR-> 5 Revenue per Share 1200.51%
P/S (Price/Sales) Close 3.52 5.49 26.12 3.40 1.15 1.20 1.86 0.85 0.78 1.15 55.02% <-IRR #YR-> 2 5 yr Running Average #DIV/0!
P/S 10 Year Median  1.51 55.02% <-IRR #YR-> 2 5 yr Running Average #DIV/0!
*Revenue in M CDN $  P/S Med 20 yr  2.46 15 yr  2.46 10 yr  2.46 5 yr  1.59 -65.38% Diff M/C
Operating Costs to Rev SAP
-$10.6 $0.0 $0.0 $0.0 $0.0 $0.0 $919.7
-$32.8 $0.0 $0.0 $0.0 $0.0 $919.7
-$193.0 $0.0 $523.5
-$193.0 $0.0 $523.5
-$0.13 $0.0 $0.0 $0.0 $0.0 $0.00 $3.69
-$0.28 $0.0 $0.0 $0.0 $0.00 $3.69
Amount -$4.7 <-12 mths -159.00% Estimates Last 12 months from Qtr
Per Share -$0.02 <-12 mths -166.67% Estimates Last 12 months from Qtr
Payout Ratio Adj EPS 0.00% 0.00% Estimates Payout Ratio EPS
Adjusted Net Income CDN$ -$2.8 -$7.8 -$1.3 $16.0 $53.7 $52.4 $8.0 384.96% <-Total Growth 6 Adjusted Profit CDN$
Return on Equity ROE -27.70% -24.46% -0.62% 2.26% 7.33% 6.83% 0.92% 0.92% <-Median-> 7 Return on Equity ROE
5Yr Median -27.70% -26.08% -24.46% -12.54% -0.62% 2.26% 2.26% -12.54% <-Median-> 7 5 Yr Median
Basic -$0.04 -$0.08 -$0.01 $0.08 $0.24 $0.22 $0.03 175.00% <-Total Growth 6 AEPS
AEPS* Dilued -$0.04 -$0.08 -$0.01 $0.08 $0.24 $0.22 $0.03 $0.37 $0.39 175.00% <-Total Growth 6 AEPS
Increase -100.00% 87.50% 900.00% 200.00% -8.33% -86.36% 1133.33% 5.41% 4 3 7 Years of Data, EPS P or N 57.14%
5 year Running Average $0.04 $0.09 $0.11 $0.19 $0.25 #NUM! <-IRR #YR-> 6 AEPS #DIV/0!
AEPS Yield -8.89% -5.13% -0.12% 1.63% 8.45% 5.71% 0.44% 7.79% 8.21% #NUM! <-IRR #YR-> 5 AEPS 137.50%
Payout Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 71.68% <-IRR #YR-> 2 5 yr Running Average #DIV/0!
5 year Running Average 0.00% 0.00% 0.00% 0.00% 0.00% 71.68% <-IRR #YR-> 2 5 yr Running Average #DIV/0!
Price/AEPS Median -12.25 -14.03 -481.50 44.38 16.33 19.50 176.33 14.88 0.00 16.33 <-Median-> 7 Price/AEPS Median
Price/AEPS High -18.25 -23.13 -841.00 27.88 21.71 26.14 235.00 19.62 0.00 21.71 <-Median-> 7 Price/AEPS High
Price/AEPS Low -6.25 -4.94 -122.00 60.88 10.96 12.86 117.67 10.14 0.00 10.96 <-Median-> 7 Price/AEPS Low
Price/AEPS Close -11.25 -19.50 -805.00 61.38 11.83 17.50 228.67 12.84 12.18 11.83 <-Median-> 7 Price/AEPS Close
Trailing P/AEPS Close -39.00 -100.63 -491.00 35.50 16.04 31.18 158.33 12.84 -11.48 <-Median-> 6 Trailing P/AEPS Close
Median Values DPR 10 Yrs 0.00% 5 Yrs   0.00% P/AEPS 5 Yrs   in order 19.50 26.14 12.86 17.50 -34.16% Diff M/C DPR 75% to 95% best
-$0.10 <-12 mths -176.92% Estimates Last 12 months from Qtr
Difference Basic and Diluted 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.62% 0.00% <-Median-> 7 Difference Basic and Diluted
EPS Basic -$0.04 -$0.08 -$0.03 -$0.23 $0.01 $0.00 $0.13 430.37% <-Total Growth 6 EPS Basic
EPS Diluted* -$0.04 -$0.08 -$0.03 -$0.23 $0.01 $0.00 $0.13 $0.04 $0.09 $0.07 425.00% <-Total Growth 6 EPS Diluted
Increase -100.00% 62.50% -666.67% 102.70% -94.41% 37400.71% -69.23% 125.00% -22.22% 3 4 7 Years of Data, EPS P or N 42.86%
Earnings Yield -8.89% -5.13% -0.37% -4.68% 0.22% 0.01% 1.90% 0.84% 1.89% 0.92% #NUM! <-IRR #YR-> 6 Earnings per Share #DIV/0!
5 year Running Average -$0.07 -$0.07 -$0.02 -$0.01 $0.05 $0.07 #NUM! <-IRR #YR-> 5 Earnings per Share 262.50%
10 year Running Average $0.00 -$0.01 -$0.02 -$0.04 -$0.04 -$0.04 -$0.02 -$0.02 -$0.01 $0.00 -42.53% <-IRR #YR-> 2 5 yr Running Average #DIV/0!
* Diluted ESP per share  E/P 10 Yrs -0.37% 5Yrs 0.01% -42.53% <-IRR #YR-> 2 5 yr Running Average #DIV/0!
$0.04 $0.00 $0.00 $0.00 $0.00 $0.00 $0.13
$0.08 $0.00 $0.00 $0.00 $0.00 $0.13
$0.07 $0.00 -$0.02
$0.07 $0.00 -$0.02
Dividend* $0.00 $0.00 $0.00 Estimates Dividend*
Increase 0.00% 0.00% 0.00% Estimates Increase
Payout Ratio EPS 0.00% 0.00% 0.00% Estimates Payout Ratio EPS
Special Dividends $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-Median-> 6 Special Dividends
Dividend* $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! <-Total Growth 5 Dividends
Payout Ratio EPS N/C N/C N/C 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% $0.00 <-Median-> 3 DPR EPS FCF 
DPR EPS 5 Yr Running #DIV/0! #DIV/0! #DIV/0! N/C N/C N/C 0.00% 0.00% 0.00% #DIV/0! <-Median-> 0 DPR EPS 5 Yr Running
Payout Ratio CFPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% #VALUE! 0.00% $0.00 <-Median-> 6 DPR CF
DPR CF 5 Yr Running 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% #VALUE! 0.00% $0.00 <-Median-> 6 DPR CF 5 Yr Running
Payout Ratio CFPS WC 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% #VALUE! 0.00% $0.00 <-Median-> 6 DPR CF WC
DPR CF WC 5 Yr Running 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% #VALUE! 0.00% $0.00 <-Median-> 6 DPR CF WC 5 Yr Running
* Dividends per share  10 Yr Med and Cur. #DIV/0! #DIV/0! 5 Yr Med and Cur. #DIV/0! #DIV/0! Last Div Inc ---> $0.00 $0.00 #DIV/0! 0.00% <-IRR #YR-> 10 Dividends #DIV/0!
Dividends Growth 15 0.00% <-IRR #YR-> 15 Dividends #DIV/0!
Dividends Growth 5 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 Dividends Growth 5
Dividends Growth 10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 Dividends Growth 10
Dividends Growth 15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 Dividends Growth 15
Div Yd
Historical Dividends Historical High Div #NUM! Low Div #NUM! 10 Yr High #NUM! 10 Yr Low #NUM! Med Div 0.00% Close Div 0.00% Historical Dividends 4.28%
High/Ave/Median Values Curr diff #NUM! #NUM! #NUM! #NUM! #NUM! #NUM! Exp. #DIV/0! Exp. #DIV/0! High/Ave/Median  10.64%
26.48%
Adjusted Historical Dividends Historical High Div #NUM! Low Div #NUM! 10 Yr High #NUM! 10 Yr Low #NUM! Med Div 0.00% Close Div 0.00% Adjusted Historical Dividends 65.88%
High/Ave/Median Values Curr diff #NUM! #NUM! #NUM! #NUM! #NUM! #NUM! Exp. #DIV/0! Exp. #DIV/0! High/Ave/Median  163.93%
Future Dividend Yield Div Yield $0.00 earning in 5 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Yield Also, assuming the same dividend increases for the future, 
Future Dividend Yield Div Yield 0.00% earning in 10 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Yield your initial cost would be covered 93.72% based on current 
Future Dividend Yield Div Yield 0.00% earning in 15 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Yield stock cost of $99.36 CDN$.
Future Dividend Paid Div Paid $0.00 earning in 5 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Paid Div Pd
Future Dividend Paid Div Paid $0.00 earning in 10 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Paid $0.00
Future Dividend Paid Div Paid $0.00 earning in 15 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Paid $0.00
$0.00
Yield if held 5 years 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 2 Paid Median Price
Yield if held 10 years #DIV/0! #NUM! <-Median-> 0 Paid Median Price
Yield if held 15 years #DIV/0! #NUM! <-Median-> 0 Paid Median Price
year 35 BMO, EMP, T, JNJ
Cost covered if held 5 years 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 2 Paid Median Price Div Yd
Cost covered if held 10 years #DIV/0! #NUM! <-Median-> 0 Paid Median Price 0.00%
Cost covered if held 15 years #DIV/0! #NUM! <-Median-> 0 Paid Median Price 0.00%
Yr  Item Tot. Grth
Revenue Growth  $32.8 $50.2 $302.3 $569.1 $776.1 $919.7 $982 <-12 mths 6.80% 2703.01% <-Total Growth 5 Revenue Growth  2703.01%
AEPS Growth -$0.08 -$0.01 $0.08 $0.24 $0.22 $0.03 -$0.02 <-12 mths -166.67% 137.50% <-Total Growth 5 AEPS Growth 137.50%
Net Income Growth -$7.8 -$3.7 -$43.8 $1.4 $0.1 $32.6 -$29 <-12 mths -189.09% 517.06% <-Total Growth 5 Net Income Growth 517.06%
Cash Flow Growth -$2.6 -$5.4 $22.3 $76.5 $66.4 $9.5 $29 <-12 mths 206.99% 461.67% <-Total Growth 5 Cash Flow Growth 461.67%
Dividend Growth $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-12 mths #DIV/0! 0.00% <-Total Growth 5 Dividend Growth 0.00%
Stock Price Growth $1.56 $8.05 $4.91 $2.84 $3.85 $6.86 $4.75 <-12 mths -30.76% 339.74% <-Total Growth 5 Stock Price Growth 339.74%
Revenue Growth  $10.6 $32.8 $50.2 $302.3 $569.1 $776.1 $919.7 $1,413 <-this year 53.64% 8609.33% <-Total Growth 6 Revenue Growth  8609.33%
AEPS Growth -$0.04 -$0.08 -$0.01 $0.08 $0.24 $0.22 $0.03 $0.37 <-this year 1133.33% 175.00% <-Total Growth 6 AEPS Growth 175.00%
Net Income Growth -$2.8 -$7.8 -$3.7 -$43.8 $1.4 $0.1 $32.6 -$19 <-this year -158.20% 1260.51% <-Total Growth 6 Net Income Growth 1260.51%
Cash Flow Growth -$1.1 -$2.6 -$5.4 $22.3 $76.5 $66.4 $9.5 $29 <-this year 206.99% 1001.18% <-Total Growth 6 Cash Flow Growth 1001.18%
Dividend Growth $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-this year #DIV/0! #DIV/0! <-Total Growth 6 Dividend Growth #DIV/0!
Stock Price Growth $0.44 $0.45 $1.56 $8.05 $4.91 $2.84 $3.85 $6.86 $4.75 <-this year -30.76% 1459.09% <-Total Growth 7 Stock Price Growth 1459.09%
Dividends on Shares $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 No of Years 7 Total Dividends 10/30/17
Share Value $1,000.12 $1,022.85 $3,545.88 $18,297.65 $11,160.43 $6,455.32 $8,751.05 $15,592.78 $10,796.75 $10,796.75 $17,388.45 $15,592.78 No of Years 7 Share Value $0.44
Total $15,592.78 Total Return 2,273.00
Graham Number AEPS $2.47 $4.14 $3.97 $1.53 $5.24 $5.38 $0.00 -37.89% <-Total Growth 3 Graham Number AEPS
Increase 67.60% -4.11% -61.35% 241.80% 2.67% -100.00% -4.11% <-Median-> 3 Increase
Price/GP Ratio Med 1.44 0.95 1.08 3.45 1.05 1.26 <-Median-> 4 Price/GP Ratio Med
Price/GP Ratio High 0.90 1.26 1.45 4.60 1.39 1.35 <-Median-> 4 Price/GP Ratio High
Price/GP Ratio Low 1.97 0.64 0.71 2.30 0.72 1.34 <-Median-> 4 Price/GP Ratio Low
Price/GP Ratio Close 1.99 0.69 0.97 4.47 0.91 0.88 #DIV/0! 1.48 <-Median-> 4 Price/GP Ratio Close
Prem/Disc Close 98.90% -31.35% -2.96% 347.39% -9.37% -11.72% #DIV/0! 47.97% <-Median-> 4 Graham Price
Graham Number EPS $0.67 $0.16 $3.19 $1.72 $2.58 $2.28 379.89% <-Total Growth 2 Graham Number EPS
Increase -76.32% 1926.79% -46.01% 50.00% -11.81% 925.23% <-Median-> 2 Increase
Price/GP Ratio Med 5.89 27.24 1.66 3.19 5.89 <-Median-> 3 Price/GP Ratio Med
Price/GP Ratio High 7.83 36.51 2.21 4.21 7.83 <-Median-> 3 Price/GP Ratio High
Price/GP Ratio Low 3.95 17.97 1.11 2.18 3.95 <-Median-> 3 Price/GP Ratio Low
Price/GP Ratio Close 4.27 24.45 2.15 2.76 1.84 3.36 4.27 <-Median-> 3 Price/GP Ratio Close
Prem/Disc Close 326.98% 2344.70% 114.92% 175.65% 83.77% 235.59% 326.98% <-Median-> 3 Graham Price
Based on EPS 3 Yrs EPS #NUM! #NUM! #NUM! #NUM! $1.84 $2.05 $2.54 #NUM! <-Total Growth -1 Based on EPS 3 Yrs EPS
Increase #NUM! #NUM! #NUM! #NUM! #NUM! 11.69% 23.54% #NUM! <-Median-> 0 Increase
Price/GP Ratio Med #NUM! #NUM! #NUM! #NUM! 2.99 #NUM! <-Median-> 0 Price/GP Ratio Med
Price/GP Ratio High #NUM! #NUM! #NUM! #NUM! 3.95 #NUM! <-Median-> 0 Price/GP Ratio High
Price/GP Ratio Low #NUM! #NUM! #NUM! #NUM! 2.04 #NUM! <-Median-> 0 Price/GP Ratio Low
Price/GP Ratio Close #NUM! #NUM! #NUM! #NUM! 2.58 2.31 3.02 #NUM! <-Median-> 0 Price/GP Ratio Close
Prem/Disc Close #NUM! #NUM! #NUM! #NUM! 158.41% 131.36% 201.60% #NUM! <-Median-> 0 Graham Price
Month, Year Dec-11 Dec-12 Dec-13 Dec-14 Dec-15 Dec-16 Dec-17 Dec-18 Dec-19 Dec-20 Dec-21 Dec-22 Dec-23 Dec-24 Dec-25 Dec-26 Dec-27 7.00 <Count Years> 7 Month, Year
Price Close $0.44 $0.45 $1.56 $8.05 $4.91 $2.84 $3.85 $6.86 $4.75 $4.75 $7.65 1459.09% <-Total Growth 7 Stock Price
Increase 2.27% 246.67% 416.03% -39.01% -42.16% 35.56% 78.18% -30.76% 0.00% 61.05% -48.82 <-Median-> 7 CAPE (10 Yr P/E)
P/E Ratio -11.25 -19.50 -268.33 -21.35 457.83 11105.98 52.77 118.75 52.78 109.29 34.47% <-IRR #YR-> 5 Stock Price
Trailing P/E Ratio -39.00 -100.63 -163.67 -12.35 620.64 19788.84 36.54 118.75 85.00 48.05% <-IRR #YR-> 7 Stock Price
CAPE (10 Yr P/E) -22.25 -20.42 -70.00 -40.55 -48.82 -59.18 -118.96 -165.69 -339.00 -1,051.09 34.47% <-IRR #YR-> 5 Price & Dividend
Median 10, 5 Yrs D.  per yr 0.00% 0.00% % Tot Ret 0.00% 0.00% T P/E -$25.67 -$12.35 P/E:  -$11.25 $52.77 -1155.56% Diff M/C 48.05% <-IRR #YR-> 7 Price & Dividend
Price 15 D.  per yr #NUM! % Tot Ret #NUM! CAPE Diff -343.22% #NUM! <-IRR #YR-> 15 Stock Price
Price & Dividend 15 #NUM! <-IRR #YR-> 15 Price & Dividend
Price  5 -$1.56 $0.00 $0.00 $0.00 $0.00 $6.86 Price  5
Price 10 -$0.44 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.86 Price 10
Price & Dividend 5 -$1.56 $0.00 $0.00 $0.00 $0.00 $6.86 Price & Dividend 5
Price & Dividend 10 -$0.44 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.86 Price & Dividend 10
Price  15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.86 Price  15
Price & Dividend 15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.86 Price & Dividend 15
Price H/L Median $0.49 $1.12 $4.82 $3.55 $3.92 $4.29 $5.29 $5.51 979.59% <-Total Growth 6 Stock Price
Increase 129.08% 328.95% -26.27% 10.42% 9.44% 23.31% 4.06% 36.35% <-IRR #YR-> 5 Stock Price 371.27%
P/E Ratio -12.25 -14.03 -160.50 -15.43 631.93 0.00 40.69 137.63 48.67% <-IRR #YR-> 6 Stock Price #DIV/0!
Trailing P/E Ratio -28.06 -60.19 -118.33 -17.04 691.58 0.00 42.35 36.35% <-IRR #YR-> 5 Price & Dividend 371.27%
P/E on Running 5 yr Average -214.26 -514.97 48.67% <-IRR #YR-> 6 Price & Dividend #DIV/0!
P/E on Running 10 yr Average -122.50 -93.54 -321.00 -93.42 -104.87 -114.87 -217.29 -270.58 -12.25 P/E Ratio Historical Median 371.27%
Median 10, 5 Yrs D.  per yr 0.00% 0.00% % Tot Ret 0.00% 0.00% T P/E -22.55 -17.04 P/E:  -12.25 0.00 Count 6 Years of data
-$1.12 $0.00 $0.00 $0.00 $0.00 $5.29
-$0.49 $0.00 $0.00 $0.00 $0.00 $0.00 $5.29
-$1.12 $0.00 $0.00 $0.00 $0.00 $5.29
-$0.49 $0.00 $0.00 $0.00 $0.00 $0.00 $5.29
High Months May Aug Oct Feb Apr May Dec Jan
Price High $0.73 $1.85 $8.41 $2.23 $5.21 $5.75 $7.05 $7.26 865.75% <-Total Growth 6 Stock Price
Increase 153.42% 354.59% -73.48% 133.63% 10.36% 22.61% 2.98% 30.68% <-IRR #YR-> 5 Stock Price 281.08%
P/E Ratio -18.25 -23.13 -280.33 -9.70 0.00 0.00 54.23 181.50 45.93% <-IRR #YR-> 6 Stock Price #DIV/0!
Trailing P/E Ratio -46.25 -105.13 -74.33 0.00 0.00 0.00 55.85 -9.70 P/E Ratio Historical Median
Median 10, 5 Yrs T P/E -23.13 0.00 P/E:  -9.70 0.00 #NUM! P/E Ratio Historical High
-$1.85 $0.00 $0.00 $0.00 $0.00 $7.05
-$0.73 $0.00 $0.00 $0.00 $0.00 $0.00 $7.05
Low Months Mar Jan Mar Dec Dec Jan Apr Apr
Price Low $0.25 $0.40 $1.22 $4.87 $2.63 $2.83 $3.53 $3.75 1312.00% <-Total Growth 6 Stock Price
Increase 58.00% 208.86% 299.18% -46.00% 7.60% 24.73% 6.23% 54.97% <-IRR #YR-> 5 Stock Price 793.67%
P/E Ratio -6.25 -4.94 -40.67 -21.17 0.00 0.00 27.15 93.75 55.47% <-IRR #YR-> 6 Stock Price #DIV/0!
Trailing P/E Ratio -9.88 -15.25 -162.33 -11.43 0.00 0.00 28.85 -4.94 P/E Ratio Historical Median
Median 10, 5 Yrs T P/E -10.65 -11.43 P/E:  -4.94 0.00 #NUM! P/E Ratio Historical Low
-$0.25 $0.00 $0.00 $0.00 $0.00 $0.00 $3.53
Free Cash Flow Mkt Sc -$6.52 $19.59 $70.14 $58.33 -$6.70 $63.90 $82.50 $95.10
Change -36.36% 686.29% 133.82% -10.06% -126.62% 470.86% 29.11%
-$40 <-12 mths -134.59%
Free Cash Flow MS -$1 -$4 -$5 $31 $72 $65 -$17 $63.90 $82.50 $95.10 -1312.30% <-Total Growth 6 Free Cash Flow
Change -215.57% 686.29% 133.82% -10.06% -126.62% 470.86% 29.11% 15.27% 34.95% <-IRR #YR-> 5 Free Cash Flow MS -347.53%
FCF/CF from Op Ratio 1.15 1.46 0.98 1.38 0.94 0.97 -1.81 2.19 #VALUE! #DIV/0! 55.47% <-IRR #YR-> 6 Free Cash Flow MS #DIV/0!
Free Cash Flow Yield -3.28% -2.14% -0.40% 3.00% 10.97% 6.96% -1.01% 5.32% 6.87% 4.92% -0.40% <-Median-> 7 Free Cash Flow Yield
Dividends paid $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! <-Total Growth 6 Dividends paid
Percentage paid 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% $0.00 <-Median-> 7 Percentage paid
5 Year Coverage 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5 Year Coverage
Dividend Coverage Ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 <-Median-> 7 Dividend Coverage Ratio
5 Year of Coverage 0.00 0.00 0.00 0.00 0.00 0.00 5 Year of Coverage
-$12 <-12 mths -14.86%
Free Cash Flow WSJ -$7 -$30 $66 $37 -$11 $63.90 $82.50 $95.10 -47.07% <-Total Growth 4 Free Cash Flow
Change -320.94% 317.49% -43.37% -128.37% 705.46% 29.11% 15.27% 10.12% <-IRR #YR-> 4 Free Cash Flow MS #DIV/0!
FCF/CF from Op Ratio 1.33 -1.36 0.86 0.56 -1.11 2.19 #VALUE! #DIV/0! 10.12% <-IRR #YR-> 4 Free Cash Flow MS #DIV/0!
Free Cash Flow Yield -0.55% -2.94% 10.01% 4.00% -0.62% 5.32% 6.87% 4.92% -0.55% <-Median-> 5 Free Cash Flow Yield
Dividends paid $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! <-Total Growth 4 Dividends paid
Percentage paid 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% $0.00 <-Median-> 5 Percentage paid
5 Year Coverage 0.00% 0.00% 0.00% 0.00% 5 Year Coverage
Dividend Coverage Ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 <-Median-> 5 Dividend Coverage Ratio
5 Year of Coverage 0.00 0.00 0.00 0.00 5 Year of Coverage
Market Cap in $M $18.0 $37.1 $180.3 $1,312.1 $1,026.9 $656.2 $929.5 $1,708.8 $1,201.3 $1,201.3 $1,934.7 #DIV/0! <-Total Growth 7 Market Cap #DIV/0!
Diluted # of Shares in Millions 23.18 71.42 91.96 133.91 190.90 220.69 236.54 254.65 250.49 250.49 250.49 #DIV/0! <-Total Growth 7 Diluted # of Shares in Million
Change 208.14% 28.75% 45.62% 42.56% 15.61% 7.18% 7.66% -1.63% 0.00% 0.00% 40.83% <-IRR #YR-> 7 Change
Difference Diluted/Basic 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -3.1% 0.0% 0.0% 0.0% 22.59% <-IRR #YR-> 5 Difference Diluted/Basic
Basic # of Shares in Millions 23.18 71.42 91.96 133.91 190.90 220.69 236.54 246.76 250.49 250.49 250.49 964.62% <-Total Growth 7 Basic
Change 208.14% 28.75% 45.62% 42.56% 15.61% 7.18% 4.32% 1.51% 0.00% 0.00% 28.75% <-Median-> 7 Change
Difference Basic/Outstanding 76.95% 15.57% 25.68% 21.72% 9.56% 4.69% 2.07% 0.94% 0.96% 0.96% 0.96% 12.57% <-Median-> 8 Difference Basic/Outstanding
$29.2 <-12 mths 206.99% Estimates last 12 months from Qtr.
# of Share in Millions 41.014 82.546 115.571 162.999 209.147 231.047 241.428 249.092 252.906 252.906 252.906 29.40% <-IRR #YR-> 7 Shares #DIV/0!
Change 101.26% 40.01% 41.04% 28.31% 10.47% 4.49% 3.17% 1.53% 0.00% 0.00% 16.60% <-IRR #YR-> 5 Shares 115.53%
Cash Flow from Operations $M -$0.6 -$1.1 -$2.6 -$5.4 $22.3 $76.5 $66.4 $9.5 $29.2 <-12 mths #DIV/0! <-Total Growth 7 Cash Flow
Increase -64.23% -149.17% -104.43% 513.74% 243.75% -13.21% -85.67% 206.99% <-12 mths Stock Options
5 year Running Average $2.5 $17.9 $31.4 $33.9 $40.8 <-12 mths 1249.39% <-Total Growth 3 CF 5 Yr Running
CFPS -$0.02 -$0.01 -$0.02 -$0.03 $0.11 $0.33 $0.28 $0.04 $0.12 <-12 mths 343.70% <-Total Growth 7 Cash Flow per Share
Increase 18.40% -77.97% -44.95% 422.45% 211.17% -16.94% -86.11% 202.36% <-12 mths #NUM! <-IRR #YR-> 7 Cash Flow #DIV/0!
5 year Running Average $0.00 $0.07 $0.13 $0.14 $0.17 <-12 mths #NUM! <-IRR #YR-> 5 Cash Flow 461.67%
P/CF on Med Price 0.00 -38.28 -49.27 -145.82 33.34 11.83 15.59 138.38 47.63 <-12 mths #NUM! <-IRR #YR-> 7 Cash Flow per Share #DIV/0!
P/CF on Closing Price -28.05 -35.16 -68.48 -243.80 46.12 8.57 13.99 179.46 41.10 <-12 mths #NUM! <-IRR #YR-> 5 Cash Flow per Share 267.80%
594.64% Diff M/C 218.71% <-IRR #YR-> 3 CFPS 5 yr Running #DIV/0!
$2.85 <-12 mths 0.00%
Excl.Working Capital CF $0.0 -$0.5 -$0.3 $1.9 $11.2 $6.1 $10.2 -$6.7 $0.0 $0.0 218.71% <-IRR #YR-> 3 CFPS 5 yr Running #DIV/0!
Cash Flow from Operations $M WC -$0.6 -$1.6 -$3.0 -$3.5 $33.5 $82.6 $76.7 $2.9 $29.2 <-12 mths 572.33% <-Total Growth 7 Cash Flow less WC
Increase -158.30% -89.56% -17.15% 1066.87% 146.84% -7.16% -96.28% 925.68% <-12 mths #NUM! <-IRR #YR-> 7 Cash Flow less WC #DIV/0!
5 year Running Average $5.0 $21.6 $37.3 $38.4 $45.0 <-12 mths #NUM! <-IRR #YR-> 5 Cash Flow less WC 196.46%
CFPS Excl. WC -$0.01 -$0.02 -$0.03 -$0.02 $0.16 $0.36 $0.32 $0.01 $0.12 <-12 mths 97.65% <-IRR #YR-> 3 CF less WC 5 Yr Run #DIV/0!
Increase -28.34% -35.39% 16.94% 853.53% 123.45% -11.16% -96.40% 910.22% <-12 mths 97.65% <-IRR #YR-> 3 CF less WC 5 Yr Run #DIV/0!
5 year Running Average $0.02 $0.09 $0.16 $0.17 $0.19 <-12 mths #NUM! <-IRR #YR-> 7 CFPS - Less WC #DIV/0!
P/CF on Median Price 0.00 -25.95 -43.91 -226.76 22.19 10.96 13.51 462.35 47.63 <-12 mths #NUM! <-IRR #YR-> 5 CFPS - Less WC 144.76%
P/CF on Closing Price -29.91 -23.83 -61.02 -379.12 30.69 7.94 12.12 599.57 41.10 <-12 mths 118.05% <-IRR #YR-> 3 CFPS 5 yr Running #DIV/0!
*Operational Cash Flow. CF/-WC P/CF Med 10 yr 5.92 5 yr  15.59 P/CF Med 10 yr 5.48 5 yr  13.51 649.61% Diff M/C 118.05% <-IRR #YR-> 3 CFPS 5 yr Running #DIV/0!
$0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.04 Cash Flow per Share
$0.02 $0.00 $0.00 $0.00 $0.00 $0.04 Cash Flow per Share
$0.00 $0.00 $0.00 $0.14 CFPS 5 yr Running
$0.00 $0.00 $0.00 $0.14 CFPS 5 yr Running
$0.6 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $2.9 Cash Flow less WC
$3.0 $0.0 $0.0 $0.0 $0.0 $2.9 Cash Flow less WC
-$5.0 $0.0 $0.0 $38.4 CF less WC 5 Yr Run
-$5.0 $0.0 $0.0 $38.4 CF less WC 5 Yr Run
$0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.01 CFPS - Less WC
$0.03 $0.00 $0.00 $0.00 $0.00 $0.01 CFPS - Less WC
For banks, use Net Income, not CF
OPM Ratio -10.01% -8.02% -10.71% 7.37% 13.45% 8.56% 1.04% 2.07% #DIV/0! <-Total Growth 6 OPM
Increase 19.81% -33.51% 168.76% 82.60% -36.35% -87.91% 99.82% Should increase  or be stable.
Diff from Median -1066% -875% -1135% 611% 1199% 727% 0% 100% 0.00 <-Median-> 7 OPM
*Operational Profit Margin (CF/Revenue) Ratio OPM 10 Yrs 1.04% 5 Yrs 7.37% should be  zero, it is a   check on calculations
$46 <-12 mths -1.56%
Adjusted EBITDA $0.97 $1.41 -$92.01 $60.36 $104.56 $113.39 $46.67 $193.40 $192.80 $206.50 4686.46% <-Total Growth 6 Adjusted EBITDA
Change 44.30% -6640.54% 165.60% 73.22% 8.45% -58.85% 314.44% -0.31% 7.11% 26.37% <-Median-> 6 Change
EBITDA Margin 9.23% 4.29% -183.14% 19.97% 18.37% 14.61% 5.07% 13.69% 12.46% 12.23% 0.09 <-Median-> 7 EBITDA Margin
Long Term Debt $0.41 $0.00 $4.70 $0.95 $290.60 $263.00 $298.91 $335.98 $385.82 #DIV/0! <-Total Growth 7 Debt Type
Change -100.00% 0.00% -79.83% 30555.78% -9.50% 13.66% 12.40% 14.84% 0.00% <-Median-> 7 Change Lg Term R
Debt/Market Cap Ratio 0.02 0.00 0.03 0.00 0.28 0.40 0.32 0.20 0.32 0.11 <-Median-> 8 Debt/Market Cap Ratio Intang/GW
Assets/Current Liabilities Ratio 0.00 5.83 6.98 11.61 9.19 9.66 9.21 4.73 4.97 8.09 <-Median-> 8 Assets/Current Liab Ratio Liquidity
Current Liabilities/Asset Ratio 1564.26 0.17 0.14 0.09 0.11 0.10 0.11 0.21 0.20 0.13 <-Median-> 8 Current Liab/Asset Ratio Liq. + CF
Debt to Cash Flow (Years) 0.00 0.00 0.00 0.00 13.05 3.44 4.50 35.28 13.20 1.72 <-Median-> 8 Debt to Cash Flow (Years) Debt Ratio
Leverage
Intangibles $11.30 $21.23 $405.52 $571.27 $555.20 $573.96 $602.89 4979.46% <-Total Growth 5 Intangibles D/E Ratio
Goodwill $8.46 $13.58 $110.12 $611.75 $499.29 $508.06 $565.12 $575.29 6580.02% <-Total Growth 6 Goodwill
Total $8.46 $24.88 $131.35 $1,017.27 $1,070.56 $1,063.26 $1,139.08 $1,178.18 #DIV/0! <-Total Growth 6 Total
Change 194.08% 427.94% 674.49% 5.24% -0.68% 7.13% 3.43% 100.61% <-Median-> 6 Change
Intangible/Market Cap Ratio 0.23 0.14 0.10 0.99 1.63 1.14 0.67 0.98 0.67 <-Median-> 7 Intangible/Market Cap Ratio
Current Assets $442.2 $3.7 $18.9 $103.4 $142.9 $150.9 $176.4 $346.1 $337.2 #DIV/0! <-Total Growth 7 Current Assets
Current Liabilities $691.8 $2.2 $8.4 $22.6 $137.3 $136.5 $153.0 $382.1 $364.7 #DIV/0! <-Total Growth 7 Current Liabilities
Liquidity Ratio 0.64 1.71 2.25 4.57 1.04 1.11 1.15 0.91 0.92 1.13 <-Median-> 8 Ratio
Liq. with CF aft div 0.64 1.23 1.94 4.33 1.20 1.67 1.59 0.93 1.00 1.59 <-Median-> 5 Liq. with CF aft div
Liq. with CF aft div (WC) 0.64 1.00 1.90 4.41 1.28 1.71 1.65 0.91 1.00 Liq. with CF aft div (WC)
Liq. CF re  Inv+Div  0.64 0.27 0.85 1.47 0.26 1.30 1.04 0.80 1.00 1.04 <-Median-> 5 Liq. CF re  Inv+Div 
Curr Long Term Debt $0.299 $0.000 $0.000 $0.753 $45.914 $34.153 $46.108 $9.384 $22.070 $34.2 <-Median-> 5 Curr Long Term Debt
Liquidity Less CLTD 0.64 1.71 2.25 4.72 1.56 1.47 1.65 0.93 0.98 1.56 <-Median-> 5 Liquidity Less CLTD
Liq. with CF aft div 0.64 1.23 1.94 4.48 1.81 2.22 2.27 0.95 1.07 2.22 <-Median-> 5 Liq. with CF aft div
Banks usually have a ratio of 1.04 or 1.05
Assets $0.4 $12.8 $58.5 $262.7 $1,262.4 $1,319.0 $1,409.3 $1,807.3 $1,812.0 #DIV/0! <-Total Growth 7 Assets
Liabilities $1.1 $2.6 $26.5 $43.8 $554.4 $503.8 $563.2 $877.6 $901.0 #DIV/0! <-Total Growth 7 Liabilities
Debt Ratio 0.40 4.86 2.21 6.00 2.28 2.62 2.50 2.06 2.01 2.39 <-Median-> 8 Ratio
Estimates BVPS $0.00 $0.00 $0.00 Estimates Estimates BVPS
Estimate Book Value $0.0 $0.0 $0.0 Estimates Estimate Book Value
P/B Ratio (Close) #DIV/0! #DIV/0! #DIV/0! Estimates P/B Ratio (Close)
Difference from 10 year median #DIV/0! Diff M/C Estimates Difference from 10 yr med.
Book Value -$0.7 $10.1 $32.0 $219.0 $708.1 $815.3 $846.1 $929.7 $911.0
NCI 0.00 0.00 $0.0 1.61 0.00 82.91 78.48 62.11 76.56
Book Value Net -$0.7 $10.1 $32.0 $217.4 $708.1 $732.3 $767.7 $867.6 $834.4 $834.4 $834.4 131201.04% <-Total Growth 7 Book Value
Book Value per share -$0.02 $0.12 $0.28 $1.33 $3.39 $3.17 $3.18 $3.48 $3.30 $3.30 $3.30 21686.52% <-Total Growth 7 Book Value per Share
Increase 861.74% 125.07% 382.07% 153.86% -6.37% 0.32% 9.54% -5.27% 0.00% 0.00% 0.40% P/B Ratio Current/Historical Median
P/B Ratio (Median) 0.00 3.99 4.06 3.61 1.05 1.24 1.35 1.52 1.67 0.00 0.00 1.43 P/B Ratio Historical Median
P/B Ratio (Close) -27.27 3.66 5.64 6.04 1.45 0.90 1.21 1.97 1.44 1.44 2.32 #NUM! <-IRR #YR-> 7 Book Value per Share #DIV/0!
Change 113.43% 54.03% 7.04% -75.97% -38.22% 35.14% 62.66% -26.90% 0.00% 61.05% 65.96% <-IRR #YR-> 5 Book Value per Share 1159.12%
Median 10 year P/B Ratio 0.00 1.99 3.99 3.80 3.61 2.42 1.35 1.43 1.52 1.43 1.43 2.42 <-Median-> 5 Median 10 year P/B Ratio
Leverage (A/BK) 0.00 1.26 1.83 1.21 1.78 1.80 1.84 2.08 2.17 1.80 <-Median-> 5 A/BV
Debt/Equity Ratio 0.00 0.26 0.83 0.20 0.78 0.69 0.73 1.01 1.08 0.73 <-Median-> 5 Debt/Eq Ratio
Shareholders' Equity (Assets less Liabilities) P/B Ratios 10 yr Med 1.43 5 yr Med 1.35 0.40% Diff M/C 1.79 Historical Leverage (A/BK)
$0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.48
-$0.28 $0.00 $0.00 $0.00 $0.00 $3.48
-$1.00 <-12 mths -101.35% Estimates last 12 months from Qtr.
Total Comprehensive Income -$5.56 -$2.80 -$7.79 -$3.34 -$24.80 $52.64 $3.07 $71.11
NCI $0.00 $0.00 $0.02 $0.44 $12.85 $17.59 $16.39 -$2.94
Shareholders -$5.56 -$2.80 -$7.82 -$3.78 -$37.66 $35.05 -$13.33 $74.05 1432.14% <-Total Growth 7 Comprehensive Income
Increase 49.60% -179.09% 51.67% -896.54% 193.06% -138.02% 655.68% 51.67% <-Median-> 5 Comprehensive Income
5 Yr Running Average -$1 -$2 -$3 -$4 -$12 -$3 -$6 $11 #NUM! <-IRR #YR-> 7 Comprehensive Income #DIV/0!
ROE 0.0% 0.0% 0.0% 0.0% 0.0% 4.8% 0.0% 8.5% #NUM! <-IRR #YR-> 5 Comprehensive Income 1047.02%
5Yr Median 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% #NUM! <-IRR #YR-> 7 5 Yr Running Average #DIV/0!
% Difference from Net Income 0.0% 0.0% 0.0% 0.0% 0.0% 2459.9% 0.0% 127.07% #NUM! <-IRR #YR-> 5 5 Yr Running Average 435.80%
Median Values Diff 5, 10 yr 0.0% 0.0% 0.0% <-Median-> 5 Return on Equity
$5.6 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $74.0
$7.8 $0.0 $0.0 $0.0 $0.0 $74.0
$1.1 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $10.9
$3.2 $0.0 $0.0 $0.0 $0.0 $10.9
Current Liability Coverage Ratio 0.00 -0.71 -0.35 -0.15 0.24 0.61 0.50 0.01 0.08   CFO / Current Liabilities
5 year Median -0.15 -0.15 0.24 0.24 0.24 0.00 <-Median-> 8 Current Liability Cov Ratio
Asset Efficiency Ratio -136.44% -12.20% -5.05% -1.32% 2.65% 6.26% 5.44% 0.16% 1.61% CFO / Total Assets
5 year Median -5.05% -1.32% 2.65% 2.65% 2.65% -0.6% <-Median-> 8 Return on Assets 
Return on Assets ROA -1256.91% -22.00% -13.36% -1.40% -3.47% 0.10% 0.01% 1.80% -1.05% Net  Income/Assets Return on Assets
5Yr Median -13.36% -3.47% -1.40% 0.01% 0.01% -2.4% <-Median-> 8 Asset Efficiency Ratio
Return on Equity ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.19% 0.01% 3.76% 0.00% Net Inc/ Shareholders' equity Return on Equity
5Yr Median 0.00% 0.00% 0.00% 0.01% 0.01% 0.0% <-Median-> 8 Return on Equity
-$29 <-12 mths -189.09% Estimates Last 12 months from Qtr
Net Income -$5.56 -$2.81 -$7.79 -$3.21 -$30.90 $18.68 $16.64 $29.10
NCI $0.00 $0.00 $0.02 $0.48 $12.89 $17.31 $16.56 -$3.51
Net Income -$5.56 -$2.81 -$7.82 -$3.69 -$43.79 $1.37 $0.08 $32.61 -$19.0 $42.6 $94.4 686.67% <-Total Growth 7 Net Income
Increase 49.45% -178.26% 52.85% -1087.78% 103.13% -94.01% 39667.07% -158.20% 324.50% 121.54% EPS/CF Ratio should not be higher than 1.00
5 Yr Running Average -$1.1 -$1.7 -$3.2 -$4.0 -$12.7 -$11.3 -$11 -$3 -$5.7 $11.5 $30.1 #NUM! <-IRR #YR-> 7 Net Income #DIV/0!
Operating Cash Flow -$0.6 -$1.1 -$2.6 -$5.4 $22.3 $76.5 $66.4 $9.5 #NUM! <-IRR #YR-> 5 Net Income 517.06%
Investment Cash Flow $0.0 -$7.7 -$10.7 -$44.2 -$499.8 -$37.9 -$81.3 -$60.2 13.41% <-IRR #YR-> 7 5 Yr Running Average #DIV/0!
Total Accruals -$4.9 $5.9 $5.5 $45.9 $433.7 -$37.3 $15.0 $83.3 -3.69% <-IRR #YR-> 5 5 Yr Running Average 17.13%
Total Assets $0.4 $12.8 $58.5 $262.7 $1,262.4 $1,319.0 $1,409.3 $1,807.3 Balance Sheet Assets
Accruals Ratio -1109.00% 46.20% 9.41% 17.47% 34.36% -2.82% 1.06% 4.61% 4.61% <-Median-> 5 Ratio
EPS/CF Ratio (WC) 0.00 0.00 0.00 0.00 0.00 0.02 0.00 11.36 0.00 <-Median-> 8 EPS/CF Ratio
$5.6 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $32.6
$7.8 $0.0 $0.0 $0.0 $0.0 $32.6
$1.1 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 -$2.7
$3.2 $0.0 $0.0 $0.0 $0.0 -$2.7
Change in Close 2.27% 246.67% 416.03% -39.01% -42.16% 35.56% 78.18% -30.76% 0.00% 61.05% Count 8 Years of data
up/down up  down down down down Count 5 62.50%
Meet Prediction? Yes Yes Yes % right Count 3 60.00%
Financial Cash Flow $1.3 $11.9 -$10.7 $120.8 $452.5 -$52.8 $10.6 $113.5 C F Statement  Financial Cash Flow
Total Accruals -$6.2 -$6.0 $16.2 -$74.9 -$18.8 $15.6 $4.3 -$30.2 Accruals
Accruals Ratio -1410.34% -46.82% 27.68% -28.52% -1.49% 1.18% 0.31% -1.67% -1.49% <-Median-> 5 Ratio
Cash $0.3 $2.2 $15.6 $86.9 $61.9 $48.9 $43.4 $131.7 $103.2 Cash
Cash per Share $0.01 $0.03 $0.14 $0.53 $0.30 $0.21 $0.18 $0.53 $0.41 $0.30 <-Median-> 5 Cash per Share
Percentage of Stock Price 1.48% 6.01% 8.68% 6.62% 6.03% 7.45% 4.67% 7.71% 8.59% 6.62% <-Median-> 5 % of Stock Price
Notes:
WELL Health Technologies company was established in February 2018 with the main offices based out of Vancouver, British Columbia, Canada. 
The company's founder and CEO is Hamed Shahbazi, previous CEO of TIO Networks, which was acquired by PayPal for $304M in 2017.
WELL Health Technologies has expanded through a number of mergers and acquisitions including the US-based CRH Medical Corp (2021), 
and ExecHealth (2021), Intrahealth Systems among others. A number of sources reported that Well Health Technologies is set to acquire 
Toronto-based MyHealth Centres, which will add 48 clinics to the company's network.
WELL Health Technologies trades on the Toronto Stock Exchange under the symbol ‘WELL’, on the OTCQX Exchange under the symbol ‘WHTCF’, 
on the Frankfurt Stock Exchange under the symbol ‘W7V’, on the Munich Stock Exchange under the symbol ‘W7U.MU’ and on the Stuttgart Stock Exchange under the symbol ‘CA94947L1022.SG’.
WELL went public in June 2017 through a reverse takeover transaction of Movarie Capital Ltd. on the TSX Venture Exchange. The Company was 
originally a yoga apparel company, a business which the company discontinued upon completion of its first acquisition of primary healthcare clinics 
in February 2018, followed by its first Electronic Medical Records acquisition in January 2019.
In November 2018, WELL Health Technologies Corp. completed the acquisition of thirteen primary healthcare clinics in British Columbia.
WELL Health Technologies Corp. did acquire MyHealth Centres in Toronto. The deal was finalized in July 2021, making 
WELL Health the largest outpatient integrated primary, specialty, and diagnostic healthcare provider in Canada. 
Sector:
Health Care.
What should this stock accomplish? Well Health Technologies Corp
375 Water Street
Suite 550
Would I buy this company and Why. Vancouver BC V6B 5C6 CAN
Why am I following this stock. 
Why I bought this stock.
I was interested in this stock when I heard it was to acquire Toronto based MyHealth Centers.
TSX stock investors can buy today is Well Health (TSX:WELL), a company that operates in the health-tech space. WELL stock has already returned over 4,000% to shareholders 
since its initial public offering in April 2016.  No Dividend.  Cantech Letter  
https://www.cantechletter.com/2025/07/well-health-technologies-has-an-increasingly-attractive-growth-profile-raymond-james-says/
Note:
Dividends
Dividends are not currently paid. 
Misson Statement or closes thing I can find.
What I am looking for is a statement that the company wants to do well by their customers, employees, and community and and thereby earn shareholders a reasonable return.
For customers 
For employees 
For community 
For investors 
How they make their money.
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: 
Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized 
CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.
Shares; '%, Value $M From Years Div. Gth Tot Ret Cap Gain Div. check Shares %, Val $M Shares %, Val $M   Change
Date 2019 5 0.00% 34.47% 34.47% 0.00% 34.47% 2022 Sep 14 2023
See below to Chairman 2017 7 0.00% 48.05% 48.05% 0.00% 48.05% 0.000 0.00% 0.000 0.00% #DIV/0!
CEO - Shares - Amount $0.000 $0.000
Options - percentage 0.000 0.00% 0.000 0.00% #DIV/0!
Options - amount $0.000 $0.000
Reuters Options Value 0.000 $0
Fong, Eva 1.705 0.68% 1.965 0.78% 15.25%
CFO - Shares - Amount $11.699 $9.336
Options - percentage 0.411 0.16% 0.153 0.06% -62.84%
Options - amount $2.818 $0.725
Ericksen, Chris 0.000 0.00% 0.000 0.00% Not found #DIV/0!
Officer - Shares - Amount $0.000 $0.000
Options - percentage 0.000 0.00% 0.000 0.00% #DIV/0!
Options - amount $0.000 $0.000
Javidan, Amir 1.985 0.80% 2.057 0.81% 3.61%
Officer - Shares - Amount $13.620 $9.771
Options - percentage 0.322 0.13% 0.153 0.06% -52.61%
Options - amount $2.209 $0.725
Lau, Sybil E. Jen 0.504 0.20% 0.548 0.22% 8.88%
Director - Shares - Amount $3.454 $2.604
Options - percentage 0.145 0.06% 0.100 0.04% -30.91%
Options - amount $0.993 $0.475
Cawkell, Ken 0.457 0.18% 0.479 0.19% 4.65%
Director - Shares - Amount $3.138 $2.274
Options - percentage 0.053 0.02% 0.004 0.00% -92.75%
Options - amount $0.363 $0.018
Shahbazi, Hamed 15.351 6.16% 15.355 6.07% 0.02%
Chairman & CEO - Shares - Amt $105.307 $72.934
Options - percentage 0.894 0.36% 0.894 0.35% 0.00%
Options - amount $6.132 $4.246
Increase in O/S Shares 5.150 2.18% 5.742 2.36% Average 0.91%
Due to Stock Options $19.827 $39.392
Book Value $24.046 $27.701
Insider Buying -$0.088 -$0.015
Insider Selling $0.208 $0.000
Net Insider Selling $0.120 -$0.015
Net Selling % of Market Cap 0.01% 0.00%
Directors 6
Women 2 33%
Minorities 2 33%
Institutions/Holdings 20 5.00%
Total Shares Held 12.660 5.01%
Increase/Decrease 3 Mths 0.694 5.80%
Starting No. of Shares 11.966
My Stock